首页> 美国卫生研究院文献>The Pan African Medical Journal >Aspects épidémiologique clinique thérapeutique et évolutif de la maladie de Basedow en Médecine Interne au CHU Ledantec Dakar (Sénégal)
【2h】

Aspects épidémiologique clinique thérapeutique et évolutif de la maladie de Basedow en Médecine Interne au CHU Ledantec Dakar (Sénégal)

机译:CHU Ledantec Dakar(塞内加尔)内科Graves病的流行病学临床治疗和进展方面

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Basedow-Graves disease is an autoimmune affection characterized by the association of thyrotoxicosis with variable frequency events such as goiter, ophthalmopathy and pretibial myxedema. Its diagnosis is often easy, while its management remains difficult. A simple medical treatment exposes patient to recurrence risk. In Senegal and Sub-Saharan Africa few studies have focused on Basedow-Graves disease. This study aims to describe the epidemiological, clinical, therapeutic and evolutionary aspects of Basedow-Graves disease at a Hospital in Dakar. This was a retrospective study conducted from 1 January 2010 to 31 December 2013 in the Department of Internal Medicine at the Aristide Le Dantec University Hospital. During this period, 108 patients receiving outpatient treatment for Basedow-Graves disease were included out of a total of 834 patients receiving outpatient treatment. The diagnosis was made on the basis of clinical, biological and immunological signs. One hundred and eight patients suffering from Basedow-Graves disease were included out of a total of 834 consultations. Sex ratio was 7.3 and the average age was 34.6 years. The main reasons for consultation were: palpitations and weight loss in 46.3% and 39.8% of cases respectively. Thyrotoxicosis syndrome was found in 93.5% of patients, goiter was found in 87% of patients and exophthalmos in 78.7% of patients. The main complication was cardiothyreosis found in 11.1% of patients. All patients underwent antithyroid synthetic drugs treatment. The evolution was favorable in 19,4% of cases. Disease recurrence was observed in 57% of cases and in 23.1% of patients were lost to follow-up. Basedow-Graves disease is the most common cause of hyperthyroidism, The patient’s clinical picture is dominated by manifestations related to hypermetabolism. This study highlights that thyroidectomy isn’t the first-line of treatment if we consider the high number of recurrences after medical treatment.
机译:Basedow-Graves疾病是一种自身免疫性疾病,其特征是甲状腺毒症与诸如甲状腺肿,眼病和胫前粘液水肿等可变频率事件相关。它的诊断通常很容易,而其管理仍然很困难。简单的药物治疗会使患者面临复发风险。在塞内加尔和撒哈拉以南非洲,很少有研究集中在Basedow-Graves疾病上。这项研究旨在描述达喀尔一家医院的Basedow-Graves病的流行病学,临床,治疗和进化方面。这是一项于2010年1月1日至2013年12月31日在阿里斯蒂德Le Dantec大学医院内科进行的回顾性研究。在此期间,在总共834名接受门诊治疗的患者中,有108名接受了Basedow-Graves疾病门诊治疗的患者包括在内。诊断是根据临床,生物学和免疫学指标进行的。在总共834次咨询中,包括了108名患有Basedow-Graves疾病的患者。性别比为7.3,平均年龄为34.6岁。进行咨询的主要原因是:心cases和体重减轻分别占46.3%和39.8%。在93.5%的患者中发现了甲状腺毒症综合征,在87%的患者中发现了甲状腺肿,在78.7%的患者中发现了眼球突出。主要的并发症是在11.1%的患者中发现了心律失常。所有患者均接受抗甲状腺合成药物治疗。 19,4%的病例进展良好。在57%的病例中观察到疾病复发,并且在失访的患者中有23.1%的患者复发。格拉夫病是甲状腺功能亢进症最常见的病因。患者的临床表现主要是与代谢亢进有关的表现。这项研究强调,如果我们考虑药物治疗后的复发率高,则甲状腺切除术不是一线治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号